Chirurgische Therapie kritischer Hyperkalzämien und hyperkalzämischer Krisen

Über 90% der Fälle mit kritischer Hyperkalzämie gehen auf eine malignomassoziierte Hyperkalzämie oder einen primären Hyperparathyreoidismus (PHPT) zurück. Die rein konservative Therapie hat eine hohe Mortalität. Wird ein PHPT hingegen frühzeitig operativ versorgt, ist von einer Überlebenschance von > 95% auszugehen. Dies zeigt die besondere Bedeutung der sofortigen interdisziplinären Behandlung, um die Therapie, die Diagnose der Grundkrankheit und das weitere Vorgehen optimal gestalten zu können.

Kernaussagen

• Die Definition einer kritischen Hyperkalzämie und einer hyperkalzämischen Krise wird nicht einheitlich gebraucht; i. d. R. werden als Grenzwerte für das Serum-Kalzium angegeben:

  • Hyperkalzämie: > 2,6 mmol Ca/l = 10,4 mg Ca/100 ml),

  • kritische Hyperkalzämie: ≥ 3,5 mmol Ca/l = 14 mg Ca/100 ml,

  • hyperkalzämische Krise: > 3,0 mmol Ca/l = 12 mg Ca/100 ml mit Vorliegen klinischer Symptome, die eine stationöre Behandlung erforderlich machen.

• Ursache von über 90% kritischer Hyperkalzämien und hyperkalzämischer Krisen ist ein primärer Hyperparathyreoidismus (PHTP) oder eine maligne Grunderkrankung.

• Die Symptomatik ist gekennzeichnet durch unspezifische Beschwerden (Schwächegefühl/Fatigue, Muskel- und Skelettbeschwerden, Übelkeit, Erbrechen und Bauchschmerzen bis hin zum akuten Abdomen).

• Mittels der zervikalen Ultraschalluntersuchung und der Sestamibi-Szintigrafie sind die meisten pathologischen Nebenschilddrüsen detektierbar.

• Ab einem Serum-Kalziumwert von > 3,0–3,1 mmol/l (12–14 mg%) ist unabhängig von zusätzlichen klinischen Symptomen umgehend eine kalziumsenkende Therapie einzuleiten, jedoch dürfen die Anstrengungen der symptomatischen Serum-Kalziumsenkung auf keinen Fall zu einer Verzögerung möglicher kurativer Therapien führen, besonders bei PHTP.

• Die Operationsindikation besteht bei kritischer Hyperkalzämie und hyperkalzämischer Krise aufgrund eines PHPT auch bei erhöhten Serum-Kalziumwerten innerhalb der ersten 48 h nach stationärer Aufnahme und sollte immer interdisziplinär getroffen werden.

• Ohne Therapie sterben alle Patient*innen mit hyperkalzämischer Krise und bei rein konservativer Therapie 14–40%. Demgegenüber liegt die Mortalitätsrate von operierten Patient*innen im Rahmen eines PHPT bei 2–6,5%.

Schlüsselwörter

primärer Hyperparathyreoidismus - Stoffwechselstörung - Nebenschilddrüse - Knochenstoffwechsel

Publikationsverlauf

Artikel online veröffentlicht:
15. Mai 2024

• Literatur

• 1 Carroll R, Matfin G. Endocrine and metabolic emergencies: hypercalcaemia. Ther Adv Endocrinol Metab 2010; 1: 225-234 DOI: 10.1177/2042018810390260. (PMID: 23148166)
• 2 Bedini I, Sylvestre Begnis G, Poenitz F. et al. Hypercalcemic crisis as a presentation of primary hyperparathyroidism. Medicina (B Aires) 2023; 83: 804-807 (PMID: 37870339)
• 3 Chan NC, Chu HM. Management of hyperparathyroid-induced hypercalcaemic crisis with intracardiac thrombi. Anaesth Rep 2019; 7: 83-87 DOI: 10.1002/anr3.12026. (PMID: 32051958)
• 4 Kaszczewska M, Chudziński W, Kaszczewski P. et al. Cystic parathyroid adenomas as a risk factor for severe hypercalcemia. J Clin Med 2023; 12: 4939 DOI: 10.3390/jcm12154939. (PMID: 37568342)
• 5 Muntaser A, Thelen A, Sehgal AR. et al. Hyperparathyroid crisis: characteristics and outcomes. Am J Surg 2023; 225: 477-480 DOI: 10.1016/j.amjsurg.2022.10.028. (PMID: 36307336)
• 6 Singh DN, Gupta SK, Kumari N. et al. Primary hyperparathyroidism presenting as hypercalcemic crisis: twenty-year experience. Indian J Endocrinol Metab 2015; 19: 100-105 DOI: 10.4103/2230-8210.131763. (PMID: 25593835)
• 7 Chen K, Xie Y, Zhao L. et al. Hyperthyroidism-associated hypercalcemic crisis: a case report and review of the literature. Medicine (Baltimore) 2017; 96: e6017 DOI: 10.1097/MD.0000000000006017. (PMID: 28121960)
• 8 das Neves MC, Rosano M, Ohe MN. et al. Planned parathyroidectomy: the new standard in hypercalcemic crisis. Arch Endocrinol Metab 2023; 67: e000613 DOI: 10.20945/2359-3997000000613. (PMID: 37252701)
• 9 Bentata Y, Benabdelhak M, Haddiya I. et al. Severe hypercalcemia requiring acute hemodialysis: a retrospective cohort study with increased incidence during the Covid-19 pandemic. Am J Emerg Med 2022; 51: 374-377 DOI: 10.1016/j.ajem.2021.11.013. (PMID: 34823193)
• 10 Phitayakorn R, McHenry CR. Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J Am Coll Surg 2008; 206: 1106-1115 DOI: 10.1016/j.jamcollsurg.2007.11.010. (PMID: 18501807)
• 11 Turan U, Kilavuz H, Irkorucu O. Clinical features of hypercalcemic crisis in primary hyperparathyroidism. Acta Endocrinol (Buchar) 2021; 17: 493-497 DOI: 10.4183/aeb.2021.493. (PMID: 35747865)
• 12 Harjit K, Zanariah H, Hisham AN. Hypercalcaemic crisis: immediate parathyroidectomy and intraoperative intravenous calcium infusion improves outcome. Asian J Surg 2007; 30: 173-177 DOI: 10.1016/s1015-9584(08)60018-4. (PMID: 17638635)
• 13 Lauschke H, Kaminski M, Stratmann H. et al. Die parathyreotoxische Krise – ein chirurgischer Notfall. Chirurg 2000; 71: 58-62 DOI: 10.1007/s001040051013.
• 14 Chen Y, Ling X, Kong W. et al. Pazopanib as salvage therapy in metastatic renal cell carcinoma with hypercalcemic crisis and renal insufficiency: a case report and literature review. Transl Cancer Res 2020; 9: 3012-3017 DOI: 10.21037/tcr.2020.02.73. (PMID: 35117659)
• 15 El-Reshaid K, Al-Bader S. Hypercalcemic crisis as a prodromal feature of Pneumcystis jiroveciipneumonia. Saudi J Kidney Dis Transpl 2018; 29: 993-996 DOI: 10.4103/1319-2442.239630. (PMID: 30152442)
• 16 de Paula ALT, Gonzaga WPF, Oliveira LM. et al. Exogenous intoxication by non-prescribed use of vitamin D, a case report. BMC Geriatr 2020; 20: 221 DOI: 10.1186/s12877-020-01614-8. (PMID: 32580697)
• 17 Zhang Y, Wang X, Liu L. et al. Hypercalcaemic crisis in a young man with extensive burns caused by heated CaCl2 solution: a case report. Burns 2014; 40: e12-e14 DOI: 10.1016/j.burns.2013.08.026. (PMID: 24011732)
• 18 Jain H, Murali S, Singh G. et al. Calcium carbonate (tums)-associated hypercalcemic crisis. Cureus 2022; 14: e32913 DOI: 10.7759/cureus.32913. (PMID: 36712775)
• 19 Seib CD, Meng T, Suh I. et al. Undertreatment of primary hyperparathyroidism in a privately insured US population: decreasing utilization of parathyroidectomy despite expanding surgical guidelines. Surgery 2021; 169: 87-93 DOI: 10.1016/j.surg.2020.04.066. (PMID: 32654861)
• 20 Fieber J, Goodsell K, Kelz RR. et al. Racial disparities in primary hyperparathyroidism. World J Surg 2021; 45: 180-187 DOI: 10.1007/s00268-020-05791-w. (PMID: 32978665)
• 21 Yu D, Tang X, Xue H. et al. Paraneoplastic syndrome in malignant lymphoma: a case report. Heliyon 2023; 9: e18968 DOI: 10.1016/j.heliyon.2023.e18968. (PMID: 37636455)
• 22 Guo Y, He L, Liu Y. et al. A rare case report of multiple myeloma presenting with paralytic ileus and type II respiratory failure due to hypercalcemic crisis. Medicine (Baltimore) 2017; 96: e9215 DOI: 10.1097/MD.0000000000009215. (PMID: 29384906)
• 23 Essouma M, Soh DM, Temgoua MN. et al. Adult T-type lymphoblastic lymphoma presenting as hypercalcemic crisis and aplastic anemia: a case report. J Med Case Rep 2019; 13: 305 DOI: 10.1186/s13256-019-2225-2. (PMID: 31594542)
• 24 Umlauf D, Bremer A, Baumgärtel MW. Ektope Calcitriol-Produktion durch ein Non-Hodgkin-Lymphom als Ursache einer hyperkalzämischen Krise. Dtsch Med Wochenschr 2014; 139: 134-138 DOI: 10.1055/s-0033-1359962. (PMID: 24430951)
• 25 Yokomoto M, Minamoto M, Utsunomiya D. et al. Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with Graves’ disease. Intern Med 2015; 54: 813-818 DOI: 10.2169/internalmedicine.54.2605. (PMID: 25832948)
• 26 Sarathi V, Karethimmaiah H, Goel A. High-dose vitamin D supplementation precipitating hypercalcemic crisis in granulomatous disorders. Indian J Endocrinol Metab 2017; 21: 815-819 DOI: 10.4103/ijem.IJEM_577_16. (PMID: 29285441)
• 27 Kiper Yılmaz HT, Tosun Taşar P, Carlioglu A. Hypercalcemic crisis in systemic lupus erythematosus. Acta Endocrinol (Buchar) 2018; 14: 102-104 DOI: 10.4183/aeb.2018.102. (PMID: 31149242)
• 28 Adeniran U, Ji B, Hussein I. et al. Parathyroid crisis: a case of elective parathyroidectomy. Cureus 2023; 15: e40251 DOI: 10.7759/cureus.40251. (PMID: 37440804)
• 29 Ameerudden S, He X. Management and surgical treatment of parathyroid crisis secondary to parathyroid tumors: report of four cases. Int Med Case Rep J 2011; 4: 59-66 DOI: 10.2147/IMCRJ.S23764. (PMID: 23754908)
• 30 Okuyama H, Sato R, Enomoto K. et al. A case of hypercalcemic crisis due to parathyroid adenoma improved by continuous hemodialysis with a common calcium concentration dialysate: discussion of therapeutic management. Intern Med 2023; DOI: 10.2169/internalmedicine.1764-23.
• 31 Gradwohl-Matis I, Franzen M, Seelmaier C. et al. Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis. ASAIO J 2015; 61: 219-223 DOI: 10.1097/MAT.0000000000000186.
• 32 Sato K. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocr J 2008; 55: 959-966 DOI: 10.1507/endocrj.k08e-092. (PMID: 18614854)
• 33 Kasperk C. Hyperkalzämische Krise und hypokalzämische Tetanie. Internist (Berl) 2017; 58: 1029-1036 DOI: 10.1007/s00108-017-0311-3. (PMID: 28835974)
• 34 Hayashi S, Oba T, Ichikawa K. et al. Hypercalcemic crisis caused by primary hyperparathyroidism in a 11-year-old boy: a rare case report and review of the literature. Gland Surg 2022; 11: 1279-1286 DOI: 10.21037/gs-22-92. (PMID: 35935565)
• 35 Sharanappa V, Mishra A, Bhatia V. et al. Pediatric primary hyperparathyroidism: experience in a tertiary care referral center in a developing country over three decades. World J Surg 2021; 45: 488-495 DOI: 10.1007/s00268-020-05816-4. (PMID: 33047232)
• 36 Xia X, Cao J, Long C. et al. Clinical characteristics of hypercalcemic crises in a tertiary children’s hospital. Endocrine 2023; 81: 175-181 DOI: 10.1007/s12020-023-03347-1. (PMID: 36897499)
• 37 Jiajue R, Song A, Wang O. et al. Persistent hypercalcemia crisis and recurrent acute pancreatitis due to multiple ectopic parathyroid carcinomas: case report and literature review of mediastinal parathyroid carcinoma. Front Endocrinol (Lausanne) 2020; 11: 647 DOI: 10.3389/fendo.2020.00647. (PMID: 33013712)
• 38 Pallauf A, Schopohl J, Makeschin M. et al. Lethal generalized calcinosis and hypercalcemic crisis in primary hyperparathyroidism. J Clin Endocrinol Metab 2015; 100: 17-18 DOI: 10.1210/jc.2014-2813. (PMID: 25343236)
• 39 Eremkina A, Krupinova J, Dobreva E. et al. Denosumab for management of severe hypercalcemia in primary hyperparathyroidism. Endocr Connect 2020; 9: 1019-1027 DOI: 10.1530/EC-20-0380. (PMID: 33112830)
• 40 Bollerslev J, Rejnmark L, Zahn A. et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol 2022; 186: R33-R63 DOI: 10.1530/EJE-21-1044. (PMID: 34863037)
• 41 Chen Y, Song A, Nie M. et al. Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort. Front Endocrinol (Lausanne) 2023; 14: 1027598 DOI: 10.3389/fendo.2023.1027598. (PMID: 36777354)
• 42 Wirowski D, Wicke C, Böhner H. et al. Presentation of 6 cases with parathyroid cysts and discussion of the literature. Exp Clin Endocrinol Diabetes 2008; 116: 501-506 DOI: 10.1055/s-2008-1058084. (PMID: 18523916)
• 43 Monsour EP, Rifai F, Chacko J. et al. A rare case of severe hypercalcemia secondary to atypical parathyroid cystic adenoma with negative sestamibi scan. Cureus 2020; 12: e6830 DOI: 10.7759/cureus.6830. (PMID: 32175203)
• 44 Kuan YC, Tan F. Hypercalcemic crisis – a fatal case of primary hyperparathyroidism. Med J Malaysia 2014; 69: 231-233 (PMID: 25934952)
• 45 Triantafyllidou M, Strobel K, Leiser A. et al. Localisation of ectopic mediastinal parathyroid adenoma by 18F-fluorocholine PET/CT. BMJ Case Rep 2018; 2018: bcr2017222089 DOI: 10.1136/bcr-2017-222089. (PMID: 29592976)
• 46 Raeymaeckers S, De Brucker Y, Vanderhasselt T. et al. Detection of parathyroid adenomas with multiphase 4DCT: towards a true four-dimensional technique. BMC Med Imaging 2021; 21: 64 DOI: 10.1186/s12880-021-00597-1. (PMID: 33827463)
• 47 Whitman J, Allen IE, Bergsland EK. et al. Assessment and comparison of ¹⁸F-Fluorocholine PET and^99mTc-Sestamibi scans in identifying parathyroid adenomas: a metaanalysis. J Nucl Med 2021; 62: 1285-1291 DOI: 10.2967/jnumed.120.257303. (PMID: 33452040)
• 48 Starker LF, Björklund P, Theoharis C. et al. Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis. World J Surg 2011; 35: 331-335 DOI: 10.1007/s00268-010-0840-6. (PMID: 21042912)
• 49 Rahimi A, Shahbazi R, Nikuei P. et al. A pediatric parathyroid carcinoma: an unusual clinical presentation and mini-review. Int J Endocrinol Metab 2021; 19: e110234 DOI: 10.5812/ijem.110234. (PMID: 33815520)
• 50 Lowell AJ, Bushman NM, Wang X. et al. Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism. J Surg Res 2017; 217: 252-257 DOI: 10.1016/j.jss.2017.06.041. (PMID: 28711370)
• 51 Yilmaz BA, Altay M, Değertekin CK. et al. Hyperparathyroid crisis presenting with hyperemesis gravidarum. Arch Gynecol Obstet 2014; 290: 811-814 DOI: 10.1007/s00404-014-3297-2.
• 52 Guthoff M, Georges G, Wehrmann M. et al. Hyperkalzämische Krise infolge eines primären Hyperparathyreoidismus. Dtsch Med Wochenschr 2008; 133: 2639-2643 DOI: 10.1055/s-0028-1105861.
• 53 Gurrado A, Piccinni G, Lissidini G. et al. Hypercalcaemic crisis due to primary hyperparathyroidism – a systematic literature review and case report. Endokrynol Pol 2012; 63: 494-502 (PMID: 23339009)
• 54 Enomoto Y, Matsuda Y, Nagamine Y. et al. Venoarterial-extra corporeal membrane oxygenation-assisted parathyroidectomy for hypercalcemic crisis due to parathyroid carcinoma complicated by severe circulatory and respiratory failure: a case report. JA Clin Rep 2023; 9: 14 DOI: 10.1186/s40981-023-00606-y. (PMID: 36914845)
• 55 Galani A, Morandi R, Dimko M. et al. Atypical parathyroid adenoma: clinical and anatomical pathologic features. World J Surg Oncol 2021; 19: 19 DOI: 10.1186/s12957-021-02123-7. (PMID: 33472651)
• 56 Miao XY, Wang XL, Lyu ZH. et al. Parathyroid carcinoma: report of 10 patients and literature review. Neuro Endocrinol Lett 2022; 43: 233-238 (PMID: 36528886)
• 57 Di Filippo G, Gobbo G, Morelli E. et al. Challenges in diagnosis and treatment of multiple atypical parathyroid tumors in a patient with extrapyramidal symptoms: case report and literature review. Gland Surg 2023; 12: 1449-1458 DOI: 10.21037/gs-23-188. (PMID: 38021203)
• 58 Liu Y, Li J, Liu H. et al. Spontaneous remission after a hypercalcemic crisis caused by an intracystic hemorrhage of bilateral parathyroid adenomas: a case report and literature review. Front Endocrinol (Lausanne) 2021; 12: 766234 DOI: 10.3389/fendo.2021.766234. (PMID: 34759892)
• 59 Chen K, Xie Y, Zhao L. et al. Hyperthyroidism-associated hypercalcemic crisis: a case report and review of the literature. Medicine (Baltimore) 2017; 96: e6017 DOI: 10.1097/MD.0000000000006017. (PMID: 28121960)
• 60 Song A, Yang Y, Liu S. et al. Prevalence of parathyroid carcinoma and atypical parathyroid neoplasms in 153 patients with multiple endocrine neoplasia type 1: case series and literature review. Front Endocrinol (Lausanne) 2020; 11: 557050 DOI: 10.3389/fendo.2020.557050. (PMID: 33101196)
• 61 Thakker RV, Newey PJ, Walls GV. et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 2012; 97: 2990-3011 DOI: 10.1210/jc.2012-1230. (PMID: 22723327)
• 62 Nastos C, Papaconstantinou D, Kofopoulos-Lymperis E. et al. Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: a meta-analysis. Surgery 2021; 169: 302-310 DOI: 10.1016/j.surg.2020.08.021. (PMID: 33008613)
• 63 Torresan F, Iacobone M. Clinical features, treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature. Int J Endocrinol 2019; 2019: 1761030 DOI: 10.1155/2019/1761030. (PMID: 31929790)
• 64 Yoshihara S, Kobayashi H, Otsuki Y. et al. Lethal visceral calcinosis in fulminant hypercalcemic crisis. Intern Med 2018; 57: 281-282 DOI: 10.2169/internalmedicine.9319-17. (PMID: 29093412)
• 65 Zagkotsis G, Markou M, Papanikolaou P. et al. Acute respiratory distress syndrome induced by parathyroid storm. Cureus 2021; 13: e12881 DOI: 10.7759/cureus.12881. (PMID: 33633910)
• 66 Gill G, Agrawal V, Kerr P. Primary hyperparathyroidism presenting as acute hypercalcemic crisis: a case report. J Otolaryngol Head Neck Surg 2023; 52: 1 DOI: 10.1186/s40463-022-00600-x. (PMID: 36627692)
• 67 Kong H, Zhang Z, Zhang H. Anesthetic considerations in hyperparathyroid crisis: a case report. Medicine (Baltimore) 2021; 100: e24216 DOI: 10.1097/MD.0000000000024216. (PMID: 33429815)